EXCEED THE SPACE PROVIDED. During the current funding period, we have discovered a number of m olecular mechanisms that underlie exercise- induced late PC. During the next funding period, we will build upon our previous work and address the following five specific Aims: 1. To establish the role of the JAK-STAT signaling pathway in exercise-induced late P C. Using our well- established murine model, we will dptermine whether exercise PC is abrogated in mice with constitutive targeted deletion of the STAT1 gene (STATI'), constitutive cardiac-specific targeted deletiop of the STAT3 gene (STAT3'), and conditional cardiac-specific targeted deletion of the STAT3 gene (cond-STAT3'). 2. To determine the mechanism whereby STAT3 is activated by exercise. We will use two genetically- engineered mice: a transgeni_._puse expressing a dominant negative STAT3 in which Tyr-705 has been replaced by phenylalanine (DN-STAT3 ''wr) and a mutant mouse in W_ Ser-727 of STAT3 has been replaced by alanine (STAT3 SALSA). We will determine whether the DN-STAT3 ..... and STAT3 SALSA mutations abrogate protection and STAT3 activation after exercise, whether the JAK and o_hePKCs-Raf-1-MEK-1/2-p44/42 MAPK cascades are activated by exercise, and whether inhibition of PKCs (PKC6' mice) blocks Ser-727 phosphorylation of STAT3. 3. To determine the relative roles of apoptosis and necrosis in the protection afforded by exercise-induced late PC. We will utilize state-of-the-art confocal microscopy techniques to identify apoptosis and necrosis with hairpin-l/caspase-3 and hairpin-2/caspase-3 dual-labeling assays, respectively. 4. To decipher the molecular mechanism by which exercise suppresses cardiac apoptosis. We will assess the effect of exercise on the expression of the major pro-apoptotic (Bak, Bax, Bid, and Bad) and anti-apoptotic (Bcl-2, Bcl-xL, Mcl-1, c-FLIPL, c-FLIPs, ARC, XIAP, clAP-l, and clAP-2) proteins in the heart. We will also assess the influence of exercise on the extrinsic and intrinsic pathways of apoptosiso 5. To determine the role of ecSOD in exercise-induced late PC and the mechanism of ecSOD upregulation. We will determine whether exercise upregulates ecSOD expression in cardiac myocytes. We will then determine whether the cardioprotective effects of exercise PC are abrogated by genetic deletion of ecSOD (ecSOD' mice) and, conversely whether they can be mimicked by cardiac-specific overexpression of ecSOD (ecSOD t,ransgenic mice). We will also investigate whether exercise activates cardiac Nrf2. Then, we will use Nrf2_ mice to conclusively establish the role of this transactivating protein in the upregulation of ecSOD by exercise. The studies outlined above will extend and complete our current analysis of the mechanism of exercise-induced late PC. Together, they will furnish novel insights into the molecular mechanisms whereby exercise promotes the shift of the heart to a defensive (preconditioned) phenotype that confers tolerance to ischemia/reperfusion injury. Besides ischemja/reperfusion injury, these data will also have broad conceptual implications for our understanding of the mechanism whereby the heart adapts to stress in general. PERFORMANCE SiTE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
4R37HL055757-11
Application #
6882813
Study Section
Special Emphasis Panel (NSS)
Program Officer
Liang, Isabella Y
Project Start
1995-05-01
Project End
2010-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
11
Fiscal Year
2005
Total Cost
$534,419
Indirect Cost
Name
University of Louisville
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
057588857
City
Louisville
State
KY
Country
United States
Zip Code
40292
Tang, Xian-Liang; Li, Qianhong; Rokosh, Gregg et al. (2016) Long-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist for at L Circ Res 118:1091-105
Muthusamy, Senthilkumar; DeMartino, Angelica M; Watson, Lewis J et al. (2014) MicroRNA-539 is up-regulated in failing heart, and suppresses O-GlcNAcase expression. J Biol Chem 289:29665-76
Bolli, Roberto; Tang, Xian-Liang; Sanganalmath, Santosh K et al. (2013) Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 128:122-31
Zafir, Ayesha; Readnower, Ryan; Long, Bethany W et al. (2013) Protein O-GlcNAcylation is a novel cytoprotective signal in cardiac stem cells. Stem Cells 31:765-75
Sanganalmath, Santosh K; Bolli, Roberto (2013) Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res 113:810-34
Stein, Adam B; Bolli, Roberto; Dawn, Buddhadeb et al. (2012) Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium. J Mol Cell Cardiol 52:228-36
Zuba-Surma, Ewa K; Guo, Yiru; Taher, Hisham et al. (2011) Transplantation of expanded bone marrow-derived very small embryonic-like stem cells (VSEL-SCs) improves left ventricular function and remodelling after myocardial infarction. J Cell Mol Med 15:1319-28
Lefer, David J; Bolli, Roberto (2011) Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation. J Cardiovasc Pharmacol Ther 16:332-9
Li, Qianhong; Guo, Yiru; Ou, Qinghui et al. (2011) Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences. Basic Res Cardiol 106:1367-77
Tang, Xian-Liang; Sanganalmath, Santosh K; Sato, Hiroshi et al. (2011) Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction. PLoS One 6:e25320

Showing the most recent 10 out of 125 publications